K-numberK254161
Device nameAutomated Aortic Stenosis Software (AutoAS)
ApplicantGE Medical Systems Ultrasound & Primary Care Diagnostics, LLC
Product codePOK
Device classClass II
Decision dateMar 27, 2026
DecisionSubstantially Equivalent
Regulation892.2060
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

AutoAS is a software application that uses artificial intelligence to analyze transthoracic echocardiography images and assist physicians in assessing moderate to severe aortic stenosis. It provides a binary classification (suggestive or not suggestive of moderate/severe AS) with an associated confidence metric, intended as a diagnostic aid to determine if further evaluation is needed. The software is not intended for standalone clinical decision-making and must be reviewed by a qualified physician.

Technological characteristics

AutoAS is a machine learning-based software that processes B-mode transthoracic cardiac ultrasound images from specific views (PLAX, PSAX-AV, AP5) to generate a two-level binary output with a study-level confidence score. It incorporates a clip annotator to verify valid image views and includes heart rate estimation for internal use. The device is designed as an accessory to compatible GE HealthCare ultrasound systems.

Test standards cited

Not stated in this summary. The document references FDA's Guidance 'Content of Premarket Submission for Device Software Functions' (June 14, 2023) for software verification and validation, and compliance with GE HealthCare's Quality Management System and ISO 13485 standards.

Substantial equivalence argument

AutoAS is substantially equivalent to EchoGo Pro (K201555) because both are machine learning-based diagnostic aids for cardiac ultrasound assessment with similar intended use, identical classification (892.2060), identical product code (POK), and identical regulation (21 CFR 892.2060). Although AutoAS assesses aortic stenosis while EchoGo Pro assesses coronary artery disease, both operate within the same anatomical area and are designed to support physician decision-making without replacing clinical judgment. Extensive performance testing demonstrated AutoAS achieves comparable or superior performance metrics (93.2% AUC, 92.4% specificity, 75.2% sensitivity) relative to expert cardiologists.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →